INTRODUCTION
Migratory polyarthritis is a common clinical feature of acute rheumatic fever (ARF)' and is one of the major criteria for its diagnosis (1) . The pathogenesis of the polyarthritis remains unknown although its relation to preceding group A streptococcal infections has been well established. While the role of complement has been investigated in several other rheumatic diseases (2-7), its status in the arthritis associated with ARF has not been described. In both rheumatoid arthritis and juvenile rheumatoid arthritis, depletion of complement within synovial fluid has been related to the presence of immune complexes and the severity of the arthritis. In the present study, therefore, we examined the status of complement and other serum proteins including immunoglobulins in synovial fluid and serum samples from 25 patients with ARF.
METHODS
Clinical material. 25 patients with joint effusion and ARF on the basis of the modified Jones criteria (1) underwent Requests for reprints should be addressed to Dr. Potter, Northwestern University, Chicago, Ill. 60611.
Received for publication 17 July 1974 and in revised form 10 March 1975. 'Abbreviations used in this paper: ARF, acute rheumatic fever; SF/S, ratio of synovial fluid to serum. aspiration of the knee joint. They had been admitted to the San Fernando General Hospital in Trinidad and examined by one of us (M. S.) as part of our ongoing studies of streptococcal infections and their complications (8) (9) (10) ). 14 of the 25 patients were males; their ages ranged from 5 to 28 yr with an average of 14 yr. 16 patients (64%) had signs of carditis during this hospitalization. All of the patients responded favorably to treatment with salicylates.
25 age-and sex-matched subj ects were selected from healthy inhabitants of a village in Trinidad which was representative of areas where many of the patients lived. Serum samples were obtained from these control subjects for comparison of serum proteins with those of the patients.
Collection of specimens. Synovial fluid and blood samples were obtained within minutes of each other soon after the patient's admission to the hospital. 10-15 ml of synovial fluid were aspirated from the knee joint through an 18-gauge needle into a plastic syringe. One portion of synovial fluid was examined for leukocytes by total and differential counts. The remainder was freed of cellular elements and clots, as were the serum samples, by centrifugation at 600 g for 20 min at room temperature. Both serum and synovial fluid samples were frozen immediately after their separation and stored at -20°C for several weeks and at -70°C thereafter until studied. When thawed, the synovial fluid samples were divided and approximately 1.5 U of hyaluronidase (Wydase, Wyeth Laboratories, Philadelphia, Pa.) was added to a 5-ml portion of each.
Assays of proteins. Total protein concentrations of both synovial fluid and serum samples were determined by the biuret method (11) . Protein electrophoresis of serum and hyaluronidase-treated synovial fluid samples was performed on cellulose acetate membranes using a Beckman model R-100 microzone electrophoresis system (Beckman Instruments, Inc., Fullerton, Calif.). The electrophoretic curve was obtained with a Beckman R-110 microzone densitometer. Albumin concentration was calculated from the total protein and the percentage of albumin on the electrophoretic curve. Concentrations of IgG, IgM, IgA, transferrin, a2-macroglobulin, Clq, C3, and C4 were determined by radial immunodiffusion (12, 13 (15) . Finally, the log of the mean SF/S value for each protein was plotted against the log of the respective protein's molecular weight according to Kushner and Somerville (14) . A regression line was ob- RESULTS Most patients experienced prompt relief of local pain after joint fluid aspiration. Neither pain nor swelling recurred in any case.
Leukocytosis was present in the synovial fluids with an average of 29,000 leukocytes/mm' (range 2,000-96,000 leukocytes/mm'). Only five samples contained less than 10,000 leukocytes/mm'. Polymorphonuclear leukocytes made up 83% of the leukocytes (average), ranging from 56 to 95%. No bacteria were observed on direct smear or in cultures of the synovial fluid samples. Total serum proteins of the patients were in the range generally considered to be normal with a mean value of 7.49 g/100 ml while they were increased in many control subjects with a mean value of 8.6 g/100 ml (Table I) . Serum albumin was decreased in the patients with ARF (P <0.01) when compared with the control subjects who had concentrations generally considered to be normal. In contrast, serum globulins were increased in both patients and control subjects and were responsible for the increased total serum proteins in the control group.
The average serum concentrations of each immunoglobulin and of Clq and C3 were significantly increased in patients when compared with the control subjects (Table II) . Serum C4 also appeared to be increased in patients with ARF but this increase was not significant (P > 0.1). Serum a2-macroglobulin and transferrin val- Fig. 2 .
All of the correlations are summarized in Table V . DISCUSSION The amount of a complement component in serum does not necessarily indicate the amount of its participation in a disease process (7) since serum levels depend on the synthesis and catabolism of complement as well as on its fixation or consumption (16) . Even so, although serum complement levels in rheumatoid arthritis usually are above normal (17, 18) , local consumption of complement has been reported within the joints in this disease (2) (3) (4) (5) . Local activation of complement also has been implicated within the central nervous system (19) and the pericardium (20) in patients with lupus erythematosus. Increased serum levels of both total complement and C3 also have been described in patients with ARF (21, 22) . However, no analysis of complement within the joints or other likely sites for its local consumption has been reported in ARF patients. This lack of information led us to examine the synovial fluid of patients with ARF for immunological clues to the pathogenesis of this arthritis.
The concentration of a serum protein in synovial fluid depends upon its concentration in the serum and the degree of synovial permeability present (23, 24) except when local synthesis or destruction occurs. Hedberg (4) showed a high correlation between complement and total protein in synovial fluids of patients with degenerative joint disease when these values were corrected for serum levels by employing the SF/S values. Likewise, the concentrations of proteins assayed in the synovial fluids of our patients with ARF correlated significantly with the total protein concentrations of the synovial fluids when corrected for their serum concentrations by employing the SF/S values. Furthermore, Kushner and Somerville (14) found that although the correlation between the mean SF/S values of nonimmune proteins and their respective molecular weights was linear in four different types of rheumatic diseases (classical rheumatoid arthritis with positive rheumatoid factor, probable rheumatoid arthritis with negative rheumatoid factor, gouty arthritis, and osteoarthritis), the slopes of the lines, which indicate the relative permeability to proteins according to molecular weights, were markedly different for each type of arthritis. Thus, the permeability of the synovium to proteins appears to depend not only on the molecular weight of the proteins and their concentration in the serum but also on the type of disease process involved. Concentrations of whole complement and complement components also were found to vary in synovial fluids from patients with different kinds of rheumatic diseases even when corrected for serum levels and synovial permeability (2) . The clinical homogeneity of the patients examined in the present study allowed us to assess the relation of complement components to each other and to immunoglobulins and other plasma proteins in a single pathogenetic type of disease.
Since the SF/S value of a protein reflects the permeability of the synovium, changes in the SF/S values of all proteins from one patient should be in the same direction if proteins are not being locally produced or destroyed. In the studies by Kushner and Somerville (14) SF/S values indicated local production of IgG and IgM in patients with classical rheumatoid arthritis. In the present study, there was no evidence for local synthesis of IgG or IgM since their mean SF/S values fell in line with the nonimmunological proteins. However, there was evidence for local consumption of the complement components. Despite the generally increased serum levels of Clq, C3, and C4 which may represent acute phase reactants (22) in our patients, these proteins were relatively decreased in synovial fluid so that the SF/S values fell below the regression line formed by the other serum proteins except for IgA. In these calculations, Clq was considered to have a mol wt of 400,000 (25) . Inasmuch as Clq is likely to be complexed with Clr and Cls in serum and synovial fluid, use of a larger mol wt might be more realistic. While the actual mol wt of the Cl complex has not been established, addition of those of the separate components results in a mol wt of around 700,000. Thus, the SF/S value for Clq (as Clqrs) may belong farther down the regression line. Although still well below the line at 700,000, the difference becomes of less significance (P < 0.1).
The apparent correlation of IgA with the complement components probably does not represent immunological activity as IgA does not fix complement by the classic pathway (26) and thus should not decrease Clq and C4. The decreased amounts of IgA in the synovial fluids may reflect instead its presence in the serum as polymers which would result in impaired passage of the larger molecules through the synovium as well as un-derestimation of the molecular weight of IgA in Fig. 2 . In addition, the use of monomer IgA for standards in our assays would give falsely low values were polymers present in serum or synovial fluids or were secretory IgA present in synovial fluid (27) .
Thus, the methods employed as used in this study indicate independently decreased synovial fluid values for C1, C4, and C3 which may be considered further evidence for activation of complement within the joints and the only evidence to date for this occurrence in ARF. Such local activation of C3 with consequent formation of chemotactic and vasoactive fragments (28) may account for the presence of many leukocytes in these synovial fluids in the absence of bacteria as well as the presence of the fluid itself. A possible role for the alternate pathway to complement should be considered in this activation as chemotactic and vasoactive factors may be released through the alternate as well as the classic pathway. In our observations, however, the earlier components were more depressed than C3 which suggests a major role for the classic rather than the alternate pathway although both may be involved. Both Cl and C3 also may be activated directly by plasmin (28) . A relationship of this activity to our observations is a distinct possibility as both fibrinogen and evidence of fibrinolysis have been observed within joint fluids in other rheumatic diseases (29) . These factors were not examined in the present study. However, C3 is more susceptible to plasmin than Clq and in turn, C4 (28) , while Clq and C4 were more depressed than C3 in the present study.
Our data, therefore, suggest that activation of complement occurs through the classic pathway within the joints of patients with ARF. If such activation were by immune complexes formed within the joint fluid, IgG or IgM should be correspondingly decreased within the fluid (unless locally increased production of immunoglobulins exactly balanced their depletion which seems unlikely), while if it were by circulating immune complexes, serum values of complement should be decreased as well as the synovial fluid values. Neither of these conditions was observed. Immune complexes formed or trapped in the synovial membranes, however, might well fix and activate complement components as they pass through, thus depleting the synovial fluid of complement and playing a major role in the local inflammation suffered by these patients with ARF. Our data favor this hypothesis.
